Eam Global Investors LLC Blueprint Medicines Corp Transaction History
Eam Global Investors LLC
- $402 Million
- Q2 2024
A detailed history of Eam Global Investors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Eam Global Investors LLC holds 41,242 shares of BPMC stock, worth $3.44 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
41,242
Previous 41,241
-0.0%
Holding current value
$3.44 Million
Previous $3.91 Million
13.62%
% of portfolio
1.1%
Previous 0.98%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
336Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$554 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$545 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$490 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$270 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$205 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $4.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...